Jennifer Good

757 total citations
20 papers, 378 citations indexed

About

Jennifer Good is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jennifer Good has authored 20 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Jennifer Good's work include Prostate Cancer Treatment and Research (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Jennifer Good is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). Jennifer Good collaborates with scholars based in United States, Canada and Brazil. Jennifer Good's co-authors include Jeremy A. Squire, Martin Petric, Frances Jamieson, Jessica Hicks, David M. Berman, Sarah B. Peskoe, Elizabeth B. Humphreys, Misop Han, Elizabeth A. Platz and Helen Fedor and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and Cancer Research.

In The Last Decade

Jennifer Good

19 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Good United States 8 173 148 108 66 44 20 378
Xue Jiang China 10 112 0.6× 182 1.2× 94 0.9× 63 1.0× 43 1.0× 30 370
Guangliang Qiang China 10 130 0.8× 95 0.6× 64 0.6× 142 2.2× 94 2.1× 25 428
Leticia T. Moreno Spain 7 66 0.4× 139 0.9× 52 0.5× 34 0.5× 142 3.2× 8 353
S. Zaidi United Kingdom 12 67 0.4× 182 1.2× 31 0.3× 53 0.8× 152 3.5× 15 419
Issachar Ben-Dov United States 7 143 0.8× 349 2.4× 78 0.7× 37 0.6× 62 1.4× 8 559
Di Jin China 12 96 0.6× 123 0.8× 68 0.6× 8 0.1× 64 1.5× 31 387
Wenman Wu China 12 56 0.3× 155 1.0× 25 0.2× 16 0.2× 40 0.9× 69 539
Ann M. Janowski United States 9 91 0.5× 455 3.1× 82 0.8× 33 0.5× 136 3.1× 10 658
Esther Yoon United States 9 59 0.3× 89 0.6× 46 0.4× 34 0.5× 65 1.5× 25 235

Countries citing papers authored by Jennifer Good

Since Specialization
Citations

This map shows the geographic impact of Jennifer Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Good more than expected).

Fields of papers citing papers by Jennifer Good

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Good. The network helps show where Jennifer Good may publish in the future.

Co-authorship network of co-authors of Jennifer Good

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Good. A scholar is included among the top collaborators of Jennifer Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Good. Jennifer Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicholson, Benjamin, et al.. (2025). Abstract 907: Identification of a stem cell-specific secretory immune regulatory ligand. Cancer Research. 85(8_Supplement_1). 907–907. 1 indexed citations
2.
Luan, Jingyun, Cynthia Truong, Weijie Guo, et al.. (2024). CD80 on skin stem cells promotes local expansion of regulatory T cells upon injury to orchestrate repair within an inflammatory environment. Immunity. 57(5). 1071–1086.e7. 15 indexed citations
3.
Kehl, Alexandra, et al.. (2024). NONDOMESTIC FELID ABC BLOOD PHENOTYPING, GENOTYPING, AND CROSSMATCHING. Journal of Zoo and Wildlife Medicine. 55(1). 143–154.
4.
Divers, Stephen J., et al.. (2021). Successful Management of Hemocoelom and Marked Anemia in a Central Bearded Dragon (Pogona vitticeps) Following Multiple Blood Transfusions and Surgery. Journal of Herpetological Medicine and Surgery. 31(2). 111–118. 2 indexed citations
5.
Koenig, Amie, et al.. (2021). Evaluation of the i-STAT Alinity v in a veterinary clinical setting. Journal of Veterinary Diagnostic Investigation. 33(4). 703–710. 5 indexed citations
6.
Koenig, Amie, et al.. (2021). Effects of a perioperative antibiotic and veterinary probiotic on fecal dysbiosis index in dogs.. PubMed. 62(3). 240–246. 6 indexed citations
7.
Rissi, Daniel R., et al.. (2019). Pancreatic Langerhans cell histiocytosis in a cat. Journal of Veterinary Diagnostic Investigation. 31(6). 859–863. 1 indexed citations
8.
Brainard, Benjamin M., et al.. (2019). Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 5—Discontinuation of anticoagulant therapy in small animals. Journal of Veterinary Emergency and Critical Care. 29(1). 88–97. 8 indexed citations
9.
Yoshimoto, Maisa, Olga Ludkovski, Jennifer Good, et al.. (2018). Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections. Laboratory Investigation. 98(4). 403–413. 14 indexed citations
10.
Kim, Helena Kyunghee, Kathrin Tyryshkin, Moyez Dharsee, et al.. (2018). Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment. Journal of Psychiatric Research. 110. 38–44. 36 indexed citations
11.
Eigl, Bernhard J., Scott North, Eric Winquist, et al.. (2015). A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195. Investigational New Drugs. 33(4). 969–976. 54 indexed citations
12.
Clarke, France, et al.. (2015). 1313. Critical Care Medicine. 43. 330–330. 1 indexed citations
13.
Troyer, Dean A., Tamara Jamaspishvili, Wei Wei, et al.. (2015). A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer. The Prostate. 75(11). 1206–1215. 46 indexed citations
14.
Lotan, Tamara L., Filipe L.F. Carvalho, Sarah B. Peskoe, et al.. (2014). PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. Modern Pathology. 28(1). 128–137. 106 indexed citations
15.
Carvalho, Filipe L.F., Tamara L. Lotan, Sarah B. Peskoe, et al.. (2014). Association of PTEN protein loss with upgrading of prostate cancer from biopsy to radical prostatectomy.. Journal of Clinical Oncology. 32(4_suppl). 127–127. 2 indexed citations
16.
Yoshimoto, Maisa, Olga Ludkovski, Jennifer Good, et al.. (2013). Abstract 63: Incorporation of flanking probes reduces truncation losses for fluorescence in situ hybridization analysis of recurrent genomic deletions in tumor sections.. Cancer Research. 73(8_Supplement). 63–63. 3 indexed citations
17.
Jamieson, Frances, et al.. (1998). Human Torovirus: A New Nosocomial Gastrointestinal Pathogen. The Journal of Infectious Diseases. 178(5). 1263–1269. 64 indexed citations
18.
Good, Jennifer. (1992). The monitoring of prothrombin time ratios in general practice--a model for chronic disease care?. PubMed. 84(4). 126–7. 2 indexed citations
19.
Good, Jennifer, et al.. (1961). Advanced neoplastic disease. Treatment with 5-fluorouracil and irradiation.. PubMed. 95. 303–8. 7 indexed citations
20.
Good, Jennifer, et al.. (1960). Treatment of advanced neoplastic disease with 5-fluorouracil and irradiation.. PubMed. 72. 119–29. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026